The TruSight Cardio panel was designed in 2015 and does not include genes implicated in DCM more recently, such as FLNC.24 In addition, RBM20 was excluded from analysis because of suboptimal sequencing coverage in ExAC. This evidence concerns the gene FLNC and familial dilated cardiomyopathy.